Hims & Hers CEO Andrew Dudum Unfazed by Market Swings, Sets Sights on Revolutionizing Healthcare's Future
Federal Appeals Court Halts Nationwide Telehealth Medication Distribution, Sending Shockwaves Through Healthcare
The Ozempic War is Over: What the Novo Nordisk and Hims & Hers Settlement Means for Your Access to GLP-1s
Novo Nordisk Doubles Down: Lawsuit Against Hims & Hers Continues Despite 'Wegovy Pill' Plans Scrapped
Unlocking Access: Tomorrow'sRx Bridges the Gap to Affordable Weight Management with Compounded GLP-1s